Nitric Oxide Deficiency in Sickle Cell Anemia: Mechanisms and Interventions

Nitric oxide (NO) deficiency plays a crucial role in the pathophysiology of sickle cell anemia (SCA), contributing to vascular dysfunction and related complications that significantly impact patient health. NO is vital for maintaining endothelial function, regulating vascular tone, and preventing platelet aggregation. In SCA, reduced NO bioavailability results from hemolysis, oxidative stress, and impaired nitric oxide synthase (NOS) activity. These factors lead to vascular issues such as pulmonary hypertension, vaso-occlusive crises, and stroke. This review explores the mechanisms behind NO depletion in SCA and emphasizes how NO deficiency worsens vascular dysfunction. The reduction of NO in SCA is mainly due to the release of cell-free hemoglobin from lysed red blood cells, which scavenges NO, along with increased production of reactive oxygen species (ROS) that break down NO. Additionally, endothelial dysfunction further decreases NO synthesis, creating a vicious cycle of declining NO availability. This causes elevated vascular resistance, impaired blood flow, and a higher risk of thrombotic events, all contributing to the morbidity and mortality observed in SCA patients. Keywords: Nitric oxide, Sickle cell anemia, Vascular dysfunction, Hemolysis, Therapeutic interventions